絞り込み

17054

広告

「The oncologist[Journal]」の検索結果

4404件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.

A phase II trial of cabozantinib in hormone-receptor positive breast cancer with bone metastases.

Clara D. Bloomfield, M.D. (1942-2020): Legacy in Leukemia Research.

Accrual, Publication Bias, and the Coronavirus in 2020.

A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting.

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.

Frequency, Timing and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data.

In Reply.

Fluoropyrimidine-Associated Cardiotoxicity: The Reply.

Fluoropyrimidine-Associated Cardiotoxicity: Probably Not So Rare As It Seems.

Are Cyclin-Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?

Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.

Impact of delayed neoadjuvant systemic chemotherapy on overall survival among breast cancer patients.

A retrospective analysis of the safety and activity of Lutetium-177-PSMA radionuclide treatment in older patients with metastatic castration-resistant prostate cancer.

Navigating roadblocks as an early career attending… literally.

Personalized risk-benefit ratio adaptation of Breast Cancer care at the epicentre of Covid-19 outbreak.

Oncologist's perspective: when cancer encounters COVID-19.

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります